BNT162b2 antigen dose and SARS-CoV-2 omicron infection in adolescents
Lancet Infect Dis
.
2023 Mar;23(3):276-277.
doi: 10.1016/S1473-3099(23)00005-1.
Epub 2023 Feb 1.
Authors
Hiam Chemaitelly
1
,
Houssein H Ayoub
2
,
Peter Coyle
3
,
Patrick Tang
4
,
Hadi M Yassine
5
,
Asmaa A Al Thani
5
,
Hebah A Al-Khatib
5
,
Mohammad R Hasan
4
,
Zaina Al-Kanaani
3
,
Einas Al-Kuwari
3
,
Andrew Jeremijenko
3
,
Anvar Hassan Kaleeckal
3
,
Ali Nizar Latif
3
,
Riyazuddin Mohammad Shaik
3
,
Hanan F Abdul-Rahim
6
,
Gheyath K Nasrallah
5
,
Mohamed Ghaith Al-Kuwari
7
,
Hamad Eid Al-Romaihi
8
,
Adeel A Butt
3
,
Mohamed H Al-Thani
8
,
Abdullatif Al-Khal
3
,
Roberto Bertollini
8
,
Laith J Abu-Raddad
9
Affiliations
1
Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, PO Box 24144, Doha, Qatar. Electronic address:
[email protected]
.
2
Department of Mathematics, Statistics, and Physics, and Biomedical Research Center, Qatar University, Doha, Qatar.
3
Hamad Medical Corporation, Doha, Qatar.
4
Department of Pathology, Sidra Medicine, Doha, Qatar.
5
Department of Biomedical Science, Qatar University, Doha, Qatar.
6
Department of Public Health, Qatar University, Doha, Qatar.
7
Primary Health Care Corporation, Doha, Qatar.
8
Ministry of Public Health, Doha, Qatar.
9
Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, PO Box 24144, Doha, Qatar; Department of Public Health, Qatar University, Doha, Qatar. Electronic address:
[email protected]
.
PMID:
36738760
PMCID:
PMC9891733
DOI:
10.1016/S1473-3099(23)00005-1
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
MeSH terms
Adolescent
Antibodies, Viral
BNT162 Vaccine*
COVID-19*
Humans
SARS-CoV-2
Substances
BNT162 Vaccine
Antibodies, Viral